Clinical Safety Outsourcing: When It Makes Sense for Biotech Companies
Clinical safety outsourcing helps biotech companies manage growing safety responsibilities without building a full clinical safety department. In early biotech clinical trials, safety activities are often handled by a combination of internal teams, CROs, and...
When Do Biotech Companies and Startups Need Pharmacovigilance
When do biotech companies and startups need pharmacovigilance? Many assume it begins after approval. This is understandable because, with limited resources, the focus remains on science, funding, clinical milestones, and product development. But in reality, clinical...
How to Build Clinical Safety for Biotechs Without a Full Department
Clinical safety management becomes essential for biotech companies earlier than many anticipate. Regulators require clear safety oversight, structured reporting, and reliable adverse event management even in early development. However, most companies at this stage...
Clinical Safety Management in Pharma: How to Manage Risk Across the Drug Development Lifecycle
Clinical trial safety management is essential across the drug development lifecycle. From first-in-human studies to late-phase development and post-marketing commitments, companies need a clear system for identifying, assessing, documenting, and acting on safety...
